Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Hu Zhu

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|April 30, 2024
Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemiaJieyu Xu, Jin Peng, Shu Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 25, 2009
[Prognostic significance of minimal residual disease detected by multiparameter flow cytometry in acute myeloid leukemia]Ya-Zhe Wang, Yan-Rong Liu, Hong-Hu Zhu, et al.
Leukemia Research|March 12, 2013
CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutationHong-Hu Zhu, Yan-Rong Liu, Hao Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trialHong-Hu Zhu, De-Pei Wu, Jie Jin, et al.
Leukemia Research|November 12, 2013
Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathwayXiao-Hui Zhang, Ru Feng, Meng Lv, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 11, 2007
Correlation of class II transactivator with HLA-DR antigen and its implicationsKai-Lin Xu, Hui Li, Xiu-Ying Pan, et al.
Leukemia & Lymphoma|July 27, 2017
The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemiaJun Kong, Xiao-Su Zhao, Ya-Zhen Qin, et al.
Chinese Medical Journal|November 22, 2007
Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCRHong-hu Zhu, Yan-rong Liu, Ya-zhen Qin, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 11, 2007
[Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction]Hong-Hu Zhu, Yan-Rong Liu, Ya-Zhen Qin, et al.
Haematologica|May 28, 2021
A Pin1/PML/P53 axis activated by retinoic acid in <i>NPM-1c</i> acute myeloid leukemiaRita Hleihel, Hiba El Hajj, Hsin-Chieh Wu, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|April 30, 2024
Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemiaJieyu Xu, Jin Peng, Shu Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 25, 2009
[Prognostic significance of minimal residual disease detected by multiparameter flow cytometry in acute myeloid leukemia]Ya-Zhe Wang, Yan-Rong Liu, Hong-Hu Zhu, et al.
Leukemia Research|March 12, 2013
CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutationHong-Hu Zhu, Yan-Rong Liu, Hao Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trialHong-Hu Zhu, De-Pei Wu, Jie Jin, et al.
Leukemia Research|November 12, 2013
Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathwayXiao-Hui Zhang, Ru Feng, Meng Lv, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 11, 2007
Correlation of class II transactivator with HLA-DR antigen and its implicationsKai-Lin Xu, Hui Li, Xiu-Ying Pan, et al.
Leukemia & Lymphoma|July 27, 2017
The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemiaJun Kong, Xiao-Su Zhao, Ya-Zhen Qin, et al.
Chinese Medical Journal|November 22, 2007
Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCRHong-hu Zhu, Yan-rong Liu, Ya-zhen Qin, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 11, 2007
[Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction]Hong-Hu Zhu, Yan-Rong Liu, Ya-Zhen Qin, et al.
Haematologica|May 28, 2021
A Pin1/PML/P53 axis activated by retinoic acid in <i>NPM-1c</i> acute myeloid leukemiaRita Hleihel, Hiba El Hajj, Hsin-Chieh Wu, et al.
Pageof 12